In Association With Novotech
Accelerating Clinical Trials
Rheumatoid arthritis in 2024: Navigating the global clinical trial landscape
As of 2020, rheumatoid arthritis affected 17.6 million globally. A new report explores the evolving landscape of rheumatoid arthritis, outlining the latest data and opportunities for the biotech and biopharma industries.